Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03681691 · ClinicalTrials.gov registry record · Phase 1
The Interaction Between Diabetes and Estradiol on Human Brain Metabolism in Postmenopausal Women
A Phase 1 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT03681691 is a Phase 1 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 12 participants.
The verdict
NCT03681691, a Phase 1 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The primary aim of this study is to test whether type 2 diabetes interacts with estradiol on brain metabolism in vivo in humans. This will be accomplished by imaging brain metabolism using positron emission tomography before and after short-term administration of transdermal 17β-estradiol in 10 postmenopausal women with diabetes and 10 non-diabetic postmenopausal women.
Interventions
- DRUG Estradiol patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-05-13 |
| Est. Completion | 2021-07-19 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03681691
The ClinicalTrials.gov registry entry for NCT03681691 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Estradiol patch is the first listed.
NCT03681691 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03681691 about?
NCT03681691 is a clinical study titled "The Interaction Between Diabetes and Estradiol on Human Brain Metabolism in Postmenopausal Women". The primary aim of this study is to test whether type 2 diabetes interacts with estradiol on brain metabolism in vivo in humans. This will be accomplished by imaging brain metabolism using positron emission tomography before and after short-term administration of transdermal 17β-estradiol in 10 post...
What is the current status of trial NCT03681691?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2019-05-13. Estimated completion is 2021-07-19.
What interventions are being tested in trial NCT03681691?
The interventions under investigation include: Estradiol patch (DRUG).
Who is sponsoring clinical trial NCT03681691?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.